Objectives

After participating in this educational activity, attendees should be able to:

1| Apply FFR CT to optimize the efficiency of patient selection for invasive cardiac testing.
2| Proposed a new paradigm of atherosclerosis quantitation and quantitation and phenotyping to optimize ASCVD prevention.
3| Apply atherosclerosis staging to select intensified therapies for the prevention of ASCVD.  


Allen Taylor MD
 

NameSpeakerFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Allen Taylor MDSpeakerHonoraria - Amgen, Inc.
Consultant - HeartFlow		No
Session date: 
10/14/2026 - 8:00am to 9:00am EDT
Location: 
Hybrid
Radiology Classroom for faculty on campus/Zoom for faculty off campus
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
Please login or register to take this course.